Sigrid Dierickx1,2, Koen Pardon3,4, Peter Pype3,2, Julie Stevens3,4, Robert Vander Stichele3,5, Luc Deliens3,2,4, Aline De Vleminck3,4. 1. End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium Sigrid.Dierickx@ugent.be. 2. Department of Public Health and Primary Care, Ghent University, Ghent, Belgium. 3. End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium. 4. Department of Family Medicine and Chronic Care, Vrije Universiteit Brussel (VUB), Brussels, Belgium. 5. Heymans Institute of Pharmacology, Ghent University, Ghent, Belgium.
Authors: Eline V T J van Lummel; Claudia Savelkoul; Eva L E Stemerdink; Dave H T Tjan; Johannes J M van Delden Journal: BMC Palliat Care Date: 2022-07-06 Impact factor: 3.113